Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice (Q46055519)

19 December 2017

title

Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice (English)

1 reference

19 December 2017

1 reference

Pedro Valdivielso

2

0 references

author name string

Arash Alipour

1

1 reference

19 December 2017

Jan Willem F Elte

3

1 reference

19 December 2017

Hans W Janssen

4

1 reference

19 December 2017

Jose Rioja

5

1 reference

19 December 2017

Noëlle van der Meulen

6

1 reference

19 December 2017

Rob van Mechelen

7

1 reference

19 December 2017

Tjin L Njo

8

1 reference

19 December 2017

Pedro González-Santos

9

1 reference

19 December 2017

Arie P Rietveld

10

1 reference

19 December 2017

Manuel Castro Cabezas

11

1 reference

19 December 2017

publication date

7 January 2012

1 reference

19 December 2017

European Journal of Clinical Investigation

published in

1 reference

19 December 2017

volume

42

1 reference

19 December 2017

issue

7

1 reference

19 December 2017

page(s)

702-708

1 reference

19 December 2017

Atherogenesis: a postprandial phenomenon

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Lipoprotein-mediated cellular mechanisms for atherogenesis in hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Postprandial lipoproteins and progression of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Fasting and daylong triglycerides in obesity with and without type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Effects of atorvastatin on fasting plasma and marginated apolipoproteins B48 and B100 in large, triglyceride-rich lipoproteins in familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Leukocyte activation by triglyceride-rich lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Postprandial apolipoprotein B48 is associated with asymptomatic peripheral arterial disease: a study in patients with type 2 diabetes and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Determination of apolipoprotein B-48 in serum by a sandwich ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for V

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Hypertriglyceridemic Very Low Density Lipoproteins Induce Triglyceride Synthesis and Accumulation in Mouse Peritoneal Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall--evidence that plaque cholesterol may be derived from post-prandial lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women. The Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Identification of lipoproteins of intestinal origin in human atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Atorvastatin markedly improves type III hyperlipoproteinemia in association with reduction of both exogenous and endogenous apolipoprotein B-containing lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

Lack of evidence for reduced plasma apo B48 catabolism in patients with heterozygous familial hypercholesterolemia carrying the same null LDL receptor gene mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02635.X

10.1111/J.1365-2362.2011.02635.X

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

22224712

1 reference

19 December 2017